Supporting Healing ♦ Teaching ♦ Research
News
26-Oct-2010
Researchers at the Hadassah Medical Center have identified the gene mutation that causes one of 20 Caucasus Jewish babies to be born with cerebellum atrophy, a severe brain defect.
26-Oct-2010
Continuing the stem cell research collaboration between the Hadassah Medical Center and the A. Alfred Taubman Medical Research Institute at the University of Michigan, Philanthropist Alfred Taubman of Detroit has donated $300,000 to Hadassah for research into the use of stem cell technology to treat Amyotrophic Lateral Sclerosis (ALS).
26-Oct-2010
To share the Hadassah Medical Center's breakthroughs in identifying gene mutations that cause serious diseases in children, Prof. Orly Elpeleg, Direct of Hadassah's Department of Genetic and Metabolic Diseases, convened Israel's first-ever Monique and Jacques Roboh Department of Genetic Research Neurogenetic Seminar. Mr. Roboh, whose generosity made possible the creation of the Research Department, is a member of the Hadassah International Board of Directors.
26-Oct-2010
Hadassah Hospital-Ein Kerem, which houses Israel’s largest kidney stone treatment center, has purchased a new, state-of-the-art lithotripter, the” Dornier Gemini.”
26-Oct-2010
Often, the Hadassah Medical Center receives emergency calls asking for help with sick or wounded diplomats stationed in Israel as well as their spouses and children; in October, however, an emergency call came regarding an American diplomat hospitalized in Amman, Jordan, who was experiencing bleeding adjacent to his brain stem.
22-Oct-2010
Dear Friends, I would like to share with you some exciting news we received during the special celebration that took place this week. On Tuesday, we held our annual Hadassah Research Day.
20-Oct-2010
Hadassah’s Cell Cure Neurosciences Ltd. has entered into an exclusive license option agreement with Teva Pharmaceutical Industries to develop and commercialize OpRegen™, Hadassah’s stem-cell product for the treatment of Age-related Macular Degeneration (AMD). Cell Cure is a subsidiary of Hadasit Bio Holdings, the Hadassah Medical Center’s technology transfer company, and BioTime, Inc.
20-Oct-2010
Israel’s Ministry of Health has given approval for the Hadassah Medical Center and BrainStorm Cell Therapeutics Inc., the leading developer of stem cell technologies, to partner for a clinical trial of BrainStorm’s stem cell treatment for Amyotrophic Lateral Sclerosis (ALS) at Hadassah.
8-Oct-2010
With the message, “This Year on Rosh Hashana (the Jewish New Year) Give the Gift of Life,” Hadassah Panama raised $15,000 for the Hadassah Medical Center Blood Bank.
8-Oct-2010
This past summer, Mexican Entrepreneur Sion Soffer consulted with Hadassah Medical Center Director General Prof. Shlomo Mor-Yosef in Jerusalem to begin planning for the development of trauma facilities in Mexico City.